Clinical Trials
14 trialsNCT02341911 2022-04-20
TNBC
Fudan University
Phase 2 Unknown
NCT04681911 2020-12-23
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2 Unknown
NCT04517292 2020-08-18
GEP
Fudan University
Phase 2 Unknown
NCT04143906 2019-10-30
Vinorelbine/Carboplatin Versus Gemcitabine/Carboplatin in Metastatic Breast Cancer
Shandong Cancer Hospital and Institute
Phase 2 Unknown
NCT03423849 2018-02-06
The Maintenance Regimen and Revised Regimen for Advanced Breast Cancer Survivors After First-line Salvage Therapy
Shandong Cancer Hospital and Institute
Phase 2/3 Unknown
NCT00408408 2017-09-18
Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By Surgery
NSABP Foundation Inc
Phase 3 Unknown
NCT02489409 2017-07-17
Recombinant Human Endostatin (EndostarTM) Injection in Treatment of Recurrent Metastatic Breast Cancer
Xinjiang Medical University
Phase 2 Unknown
NCT03006614 2017-01-16
PERS
Sun Yat-sen University
Phase 3 Unknown
NCT02207335 2015-12-22
Trial of Gemcitabine_Capecitabine Versus Gemcitabine_Carboplatin in Breast Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 3 Unknown
NCT02544243 2015-09-09
Vinorelbine/Gemcitabine Versus Vinorelbine/Cisplatin in Metastatic Breast Cancer
Shandong Cancer Hospital and Institute
Phase 2 Unknown
NCT00027989 2013-12-18
Liposomal Doxorubicin and Gemcitabine in Treating Women With Metastatic Breast Cancer
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00039546 2013-08-07
Combination Chemotherapy in Treating Women With Breast Cancer Who Have Undergone Surgery
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00070278 2013-08-07
Neoadjuvant Epirubicin, Cyclophosphamide, and Paclitaxel With or Without Gemcitabine in Treating Women Who Are Undergoing Surgery for Early Breast Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT01352494 2011-05-27
NeoTG
Korean Breast Cancer Study Group
Phase 2 Unknown